Pseudohypoparathyroidism

A hereditary syndrome clinically similar to HYPOPARATHYROIDISM. It is characterized by HYPOCALCEMIA; HYPERPHOSPHATEMIA; and associated skeletal development impairment and caused by failure of response to PARATHYROID HORMONE rather than deficiencies. A severe form with resistance to multiple hormones is referred to as Type 1a and is associated with maternal mutant allele of the ALPHA CHAIN OF STIMULATORY G PROTEIN.

Subtype terms (1)

More specific conditions that are subtypes of Pseudohypoparathyroidism in the MeSH hierarchy.

Pseudopseudohypoparathyroidism
1 drug approved

Drugs by status

Phase 4 trials (1)

theophylline

Phase 3 trials (1)

somatropin

Phase 2 trials (1)

sodium thiosulfate

Organizations

Organization Involved with Phase 4 Indications (1)

Harvard University

Organization Involved with Phase 3 Indications (3)

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
National Institutes of Health (NIH)
Johns Hopkins University

Organization Involved with Phase 2 Indications (1)

Vanderbilt University

Organization Involved with Other Experimental Indications (2)

Eli Lilly
University of Milan